Australia
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.64 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 54.30 M
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
3 |
USD 44.11 M
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
4 |
USD 20.95 M
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
5 |
USD 20.40 M
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
6 |
USD 17.49 M
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
7 |
USD 13.82 M
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
8 |
USD 9.96 M
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
9 |
USD 5.04 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
10 |
USD 865.07 K
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
The Clinical Trials company in Australia with the highest Receivables is CSL Limited (ASX: CSL.AX) at USD 2.64 B.
The Clinical Trials company in Australia with the lowest Receivables is Anteris Technologies Ltd (ASX: AVR.AX) at USD 865.07 K.
The top 10 Clinical Trials companies in Australia by Receivables are CSL Limited, Australian Clinical Labs Limited, Telix Pharmaceuticals Limited, Mesoblast Limited, Monash IVF Group Limited, Clinuvel Pharmaceuticals Limited, PolyNovo Limited, Cogstate Limited, Immutep Limited and Anteris Technologies Ltd.
The bottom 10 Clinical Trials companies in Australia by Receivables are Anteris Technologies Ltd, Immutep Limited, Cogstate Limited, PolyNovo Limited, Clinuvel Pharmaceuticals Limited, Monash IVF Group Limited, Mesoblast Limited, Telix Pharmaceuticals Limited, Australian Clinical Labs Limited and CSL Limited.